Rapid Microbiology Testing Market is Expected to Reach $8.3 billion | MarketsandMarkets™

Chicago, April 19, 2024 (GLOBE NEWSWIRE) — Rapid Microbiology Testing market in terms of revenue was estimated to be worth $5.2 billion in 2024 and is poised to reach $8.3 billion by 2029, growing at a CAGR of 10.1% from 2024 to 2029 according to a latest report published by MarketsandMarkets™.

The increasing use of rapid microbiology testing products can be attributed to their ability to provide quick and reliable results. These products are cost-effective and can often lead to cost savings compared to traditional methods, which is a significant factor driving their uptake. Continuous technological advancements improve their sensitivity and specificity, making them more competitive. Collaborations among industry stakeholders also accelerate the successful implementation of these products, particularly in addressing global health challenges and emerging infectious threats.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=31548521

Rapid Microbiology Testing Market Scope:

Report Coverage Details
Market Revenue in 2024 $5.2 billion
Estimated Value by 2029 $8.3 billion
Growth Rate Poised to grow at a CAGR of 10.1%
Market Size Available for 2022–2029
Forecast Period 2024–2029
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, method, and application
Geographies Covered North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Opportunities for growth in developing countries
Key Market Driver Technological advancements in rapid microbiology testing

Based on product, the rapid microbiology testing market is broadly classified into instruments (automated microbial identification & antimicrobial susceptibility testing systems, mass spectrometers, bioluminescence & fluorescence-based detection systems, PCR systems, cytometers, active air samplers, and other instruments), reagents & kits (sterility testing reagents & kits and other reagent & kits), and consumables.  In 2023, the largest market share was held by the instruments segment. Instruments in rapid microbiology testing are often automated, allowing for faster and more efficient testing processes. Automation reduces the time required for sample preparation, analysis, and result generation, making it an attractive option for laboratories and industries prioritizing quick turnaround times.

Categorized by method, the rapid microbiology testing market is segmented into growth-based, cellular component-based, nucleic acid-based, viability-based, and other rapid microbiology testing methods. In 2023, the largest share of the rapid microbiology testing market was held by the growth-based rapid microbiology testing segment. The large share of this segment can be attributed to factors such as the limited requirement of skilled professionals and supportive government regulations. Also the growth-based rapid microbiology testing methods have applications across a wide range of industries, including pharmaceuticals, food and beverages, clinical diagnostics, and environmental monitoring. This broad applicability contributes to their dominance in the microbiology testing market.

Categorized by application, the rapid microbiology testing market is divided into clinical disease diagnosis, industrial testing, and research applications. In 2023, the industrial testing segment accounted for the predominant share of the rapid microbiology testing market. The dominance of the industrial testing segment in the rapid microbiology testing market is propelled by the stringent quality control requirements in industries such as pharmaceuticals, food and beverage, and cosmetics. These industries heavily rely on rapid microbiology testing to ensure product safety, meet regulatory standards, and maintain manufacturing processes efficiency.

The global rapid microbiology testing market has been segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is expected to offer significant growth opportunities for players operating in the rapid microbiology testing market during the forecast period, primarily due to the increasing healthcare expenditure and growing initiatives to promote the use of advanced rapid microbiology testing technologies in Asia Pacific countries.

Buy a Rapid Microbiology Testing Industry Report (331 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=31548521

Rapid Microbiology Testing market major players covered in the report, such as:

  • bioMérieux SA (France)
  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • Abbott Laboratories (US)
  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Sartorius AG (Germany)
  • Bruker (US)
  • QuidelOrtho Corporation (US)
  • Charles River Laboratories (US)
  • Neogen Corporation (US)
  • Don Whitley Scientific Limited (UK)
  • Rapid Micro Biosystems, Inc. (US)
  • Gradientech (Sweden)
  • rqmicro AG (Switzerland)
  • Colifast AS (Norway)
  • Serosep Limited (Ireland)
  • Solus PerkinElmer (US)
  • BTNX Inc. (Canada)
  • R-Biopharm AG (Germany)
  • Paragon Genomics, Inc. (US)
  • Kypha Inc. (US)
  • Vivione Biosciences (US)
  • Bactest Ltd. (UK)
  • CorDx (US)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=31548521

This report categorizes the rapid microbiology testing market based on product, method, application, and region:

By Product

  • Instruments
    • Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
    • Mass Spectrometers
    • PCR Systems
    • Bioluminescence & Fluorescence-based Detection Systems
    • Cytometers
    • Active Air Samplers
    • Other Instruments
  • Reagents & Kits
    • Sterility Testing Reagents & Kits
    • Other Reagents & Kits
  • Consumables

By Method

  • Growth-based Rapid Microbiology Testing
  • Cellular Component-based Rapid Microbiology Testing
  • Nucleic Acid-based Rapid Microbiology Testing
  • Viability-based Rapid Microbiology Testing
  • Other Rapid Microbiology Testing Methods

By Application

  • Clinical Disease Diagnosis
  • Industrial Testing
    • Food & Beverage Testing
    • Pharmaceutical & Biological Drug Testing
    • Environmental Testing
    • Cosmetics & Personal Care Products Testing
    • Other Industrial Testing Applications
  • Research Applications

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
  • GCC Countries

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=31548521

Key Market Stakeholders:

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives:

  • To define, describe, segment, and forecast the rapid microbiology testing market by product, method, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as acquisitions, collaborations, partnerships, agreements, and product launches & approvals in the rapid microbiology testing market
  • To benchmark players within the market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Related Reports:

In Vitro Diagnostics Market

Molecular Diagnostics Market

Laboratory Proficiency Testing Market

Antimicrobial Susceptibility Testing Market

Clinical Microbiology Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/rapid-microbiology-testing-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/rapid-microbiology-testing.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.